Common anesthetic used in preclinical PET imaging inhibits metabolism of the PET tracer [18F]3F4AP
© 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry..
Positron emission tomography (PET) imaging studies in laboratory animals are almost always performed under isoflurane anesthesia to ensure that the subject stays still during the image acquisition. Isoflurane is effective, safe, and easy to use, and it is generally assumed to not have an impact on the imaging results. Motivated by marked differences observed in the brain uptake and metabolism of the PET tracer 3-[18F]fluoro-4-aminopyridine [(18F]3F4AP) between human and nonhuman primate studies, this study investigates the possible effect of isoflurane on this process. Mice received [18F]3F4AP injection while awake or under anesthesia and the tracer brain uptake and metabolism was compared between groups. A separate group of mice received the known cytochrome P450 2E1 inhibitor disulfiram prior to tracer administration. Isoflurane was found to largely abolish tracer metabolism in mice (74.8 ± 1.6 vs. 17.7 ± 1.7% plasma parent fraction, % PF) resulting in a 4.0-fold higher brain uptake in anesthetized mice at 35 min post-radiotracer administration. Similar to anesthetized mice, animals that received disulfiram showed reduced metabolism (50.0 ± 6.9% PF) and a 2.2-fold higher brain signal than control mice. The higher brain uptake and lower metabolism of [18F]3F4AP observed in anesthetized mice compared to awake mice are attributed to isoflurane's interference in the CYP2E1-mediated breakdown of the tracer, which was confirmed by reproducing the effect upon treatment with the known CYP2E1 inhibitor disulfiram. These findings underscore the critical need to examine the effect of isoflurane in PET imaging studies before translating tracers to humans that will be scanned without anesthesia.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Journal of neurochemistry - (2024) vom: 01. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ramos-Torres, Karla [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
[18F]3F4AP |
|---|
| Anmerkungen: |
Date Revised 13.05.2024 published: Print-Electronic UpdateOf: bioRxiv. 2023 Dec 14;:. - PMID 38168265 Citation Status Publisher |
|---|
| doi: |
10.1111/jnc.16118 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371794870 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371794870 | ||
| 003 | DE-627 | ||
| 005 | 20240513232441.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240501s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jnc.16118 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1406.xml |
| 035 | |a (DE-627)NLM371794870 | ||
| 035 | |a (NLM)38690718 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ramos-Torres, Karla |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Common anesthetic used in preclinical PET imaging inhibits metabolism of the PET tracer [18F]3F4AP |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.05.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a UpdateOf: bioRxiv. 2023 Dec 14;:. - PMID 38168265 | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. | ||
| 520 | |a Positron emission tomography (PET) imaging studies in laboratory animals are almost always performed under isoflurane anesthesia to ensure that the subject stays still during the image acquisition. Isoflurane is effective, safe, and easy to use, and it is generally assumed to not have an impact on the imaging results. Motivated by marked differences observed in the brain uptake and metabolism of the PET tracer 3-[18F]fluoro-4-aminopyridine [(18F]3F4AP) between human and nonhuman primate studies, this study investigates the possible effect of isoflurane on this process. Mice received [18F]3F4AP injection while awake or under anesthesia and the tracer brain uptake and metabolism was compared between groups. A separate group of mice received the known cytochrome P450 2E1 inhibitor disulfiram prior to tracer administration. Isoflurane was found to largely abolish tracer metabolism in mice (74.8 ± 1.6 vs. 17.7 ± 1.7% plasma parent fraction, % PF) resulting in a 4.0-fold higher brain uptake in anesthetized mice at 35 min post-radiotracer administration. Similar to anesthetized mice, animals that received disulfiram showed reduced metabolism (50.0 ± 6.9% PF) and a 2.2-fold higher brain signal than control mice. The higher brain uptake and lower metabolism of [18F]3F4AP observed in anesthetized mice compared to awake mice are attributed to isoflurane's interference in the CYP2E1-mediated breakdown of the tracer, which was confirmed by reproducing the effect upon treatment with the known CYP2E1 inhibitor disulfiram. These findings underscore the critical need to examine the effect of isoflurane in PET imaging studies before translating tracers to humans that will be scanned without anesthesia | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a PET imaging | |
| 650 | 4 | |a [18F]3F4AP | |
| 650 | 4 | |a anesthesia | |
| 650 | 4 | |a metabolism | |
| 650 | 4 | |a radiometabolites | |
| 650 | 4 | |a radiotracer | |
| 700 | 1 | |a Sun, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Kazue |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yu-Peng |e verfasserin |4 aut | |
| 700 | 1 | |a Brugarolas, Pedro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurochemistry |d 1956 |g (2024) vom: 01. Mai |w (DE-627)NLM000006211 |x 1471-4159 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:01 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jnc.16118 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 01 |c 05 | ||